Lpl Financial LLC Alaunos Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.04 - $0.13 $937 - $3,046	23,431 New	23,431 $1,000
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $7,051 - $13,307	-11,374 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.89 $2,639 - $4,577	-2,422 Reduced 17.56%	11,374 $12,000
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $23,983 - $45,468	-16,655 Reduced 54.69%	13,796 $25,000
Q2 2021 Aug 13, 2021	SELL	$2.63 - $3.67 $5,457 - $7,615	-2,075 Reduced 6.38%	30,451 $80,000
Q1 2021 May 14, 2021	SELL	$2.82 - $5.6 $3,172 - $6,300	-1,125 Reduced 3.34%	32,526 $117,000
Q4 2020 Feb 12, 2021	SELL	$2.09 - $3.09 $21,161 - $31,286	-10,125 Reduced 23.13%	33,651 $85,000
Q3 2020 Nov 09, 2020	BUY	$2.39 - $3.43 $3,202 - $4,596	1,340 Added 3.16%	43,776 $110,000
Q2 2020 Aug 13, 2020	BUY	$2.2 - $3.71 $7,392 - $12,465	3,360 Added 8.6%	42,436 $139,000
Q1 2020 May 14, 2020	SELL	$1.9 - $4.98 $1,732 - $4,541	-912 Reduced 2.28%	39,076 $96,000
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $2,279 - $3,086	-577 Reduced 1.42%	39,988 $189,000
Q3 2019 Nov 13, 2019	SELL	$4.13 - $6.94 $13,860 - $23,290	-3,356 Reduced 7.64%	40,565 $174,000
Q2 2019 Aug 09, 2019	BUY	$3.98 - $6.2 $3,980 - $6,200	1,000 Added 2.33%	43,921 $256,000
Q1 2019 May 08, 2019	BUY	$2.0 - $4.4 $1,450 - $3,190	725 Added 1.72%	42,921 $165,000
Q4 2018 Feb 07, 2019	SELL	$1.61 - $3.62 $5,433 - $12,217	-3,375 Reduced 7.41%	42,196 $79,000
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $3,625 - $5,245	-1,604 Reduced 3.4%	45,571 $146,000
Q2 2018 Aug 14, 2018	BUY	$3.02 - $4.94 $1,208 - $1,976	400 Added 0.86%	47,175 $142,000
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $1,494 - $2,220	432 Added 0.93%	46,775 $183,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $133,464 - $218,213	33,366 Added 257.12%	46,343 $192,000
Q3 2017 Nov 14, 2017	SELL	$4.99 - $6.57 $479 - $630	-96 Reduced 0.73%	12,977 $80,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,073	13,073 $81,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $493M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account